D-PHE7-SUBSTITUTED PEPTIDE BRADYKININ ANTAGONISTS ARE NOT SUBSTRATES FOR KININASE-II

被引:33
作者
TOGO, J [1 ]
BURCH, RM [1 ]
DEHAAS, CJ [1 ]
CONNOR, JR [1 ]
STERANKA, LR [1 ]
机构
[1] NOVA PHARMACEUT CORP, 6200 FREEPORT CTR, BALTIMORE, MD 21224 USA
关键词
D O I
10.1016/0196-9781(89)90085-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:109 / 112
页数:4
相关论文
共 11 条
[1]   ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS [J].
Antonaccio, MJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1982, 22 :57-87
[2]   VASODEPRESSOR ROLE OF ENDOGENOUS BRADYKININ ASSESSED BY A BRADYKININ ANTAGONIST [J].
BENETOS, A ;
GAVRAS, H ;
STEWART, JM ;
VAVREK, RJ ;
HATINOGLOU, S ;
GAVRAS, I .
HYPERTENSION, 1986, 8 (11) :971-974
[3]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[4]  
Erdos E., 1979, HDB EXPT PHARM S, VXXV, P427
[5]  
ERDOS EG, 1966, HYPOTENSIVE PEPTIDES, P235
[6]  
MILLER DH, 1988, IN PRESS ENDOCRINOLO
[7]   PURIFICATION OF ANGIOTENSIN I-CONVERTING ENZYME FROM HUMAN LUNG [J].
NISHIMURA, K ;
YOSHIDA, N ;
HIWADA, K ;
UEDA, E ;
KOKUBU, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 483 (02) :398-408
[8]   SUBSTRATE REQUIREMENTS FOR ANGIOTENSIN-I CONVERSION IN-VIVO AND IN-VITRO [J].
OPARIL, S ;
KOERNER, T ;
TREGEAR, GW ;
BARNES, BA ;
HABER, E .
CIRCULATION RESEARCH, 1973, 33 (04) :415-423
[9]   NASAL PROVOCATION WITH BRADYKININ INDUCES SYMPTOMS OF RHINITIS AND A SORE THROAT [J].
PROUD, D ;
REYNOLDS, CJ ;
LACAPRA, S ;
KAGEYSOBOTKA, A ;
LICHTENSTEIN, LM ;
NACLERIO, RM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03) :613-616
[10]  
REGOLI D, 1980, PHARMACOL REV, V32, P1